593 related articles for article (PubMed ID: 17636787)
1. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
Keller TT; Squizzato A; Middeldorp S
Cochrane Database Syst Rev; 2007 Jul; (3):CD005158. PubMed ID: 17636787
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
Squizzato A; Keller T; Romualdi E; Middeldorp S
Cochrane Database Syst Rev; 2011 Jan; (1):CD005158. PubMed ID: 21249668
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.
Squizzato A; Bellesini M; Takeda A; Middeldorp S; Donadini MP
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005158. PubMed ID: 29240976
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
Valentine N; Van de Laar FA; van Driel ML
Cochrane Database Syst Rev; 2012 Nov; 11():CD005449. PubMed ID: 23152231
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.
Main C; Palmer S; Griffin S; Jones L; Orton V; Sculpher M; Henderson R; Sudlow C; Hawkins N; Riemsma R
Health Technol Assess; 2004 Oct; 8(40):iii-iv, xv-xvi, 1-141. PubMed ID: 15461878
[TBL] [Abstract][Full Text] [Related]
6. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
7. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.
Rogowski W; Burch J; Palmer S; Craigs C; Golder S; Woolacott N
Health Technol Assess; 2009 Jun; 13(31):iii-iv, ix-xi, 1-77. PubMed ID: 19573471
[TBL] [Abstract][Full Text] [Related]
8. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Sudlow CL; Mason G; Maurice JB; Wedderburn CJ; Hankey GJ
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD001246. PubMed ID: 19821273
[TBL] [Abstract][Full Text] [Related]
9. Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.
Helton TJ; Bavry AA; Kumbhani DJ; Duggal S; Roukoz H; Bhatt DL
Am J Cardiovasc Drugs; 2007; 7(4):289-97. PubMed ID: 17696569
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL; Topol EJ;
Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
[TBL] [Abstract][Full Text] [Related]
11. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Hankey GJ; Sudlow CL; Dunbabin DW
Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
[TBL] [Abstract][Full Text] [Related]
12. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.
Chen J; Bhatt DL; Dunn ES; Shi C; Caro JJ; Mahoney EM; Gabriel S; Jackson JD; Topol EJ; Cohen DJ
Value Health; 2009 Sep; 12(6):872-9. PubMed ID: 19490556
[TBL] [Abstract][Full Text] [Related]
14. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
Antithrombotic Trialists' Collaboration
BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Bedenis R; Lethaby A; Maxwell H; Acosta S; Prins MH
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD000535. PubMed ID: 25695213
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
Shantsila E; Lip GY
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy and anticoagulation in patients with hypertension.
Griffin G
Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents and anticoagulants for hypertension.
Lip GY; Felmeden DC
Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
[TBL] [Abstract][Full Text] [Related]
20. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
Mehta SR; Yusuf S;
Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
